Fucikova, Jitka
Kepp, Oliver http://orcid.org/0000-0002-6081-9558
Kasikova, Lenka
Petroni, Giulia
Yamazaki, Takahiro
Liu, Peng http://orcid.org/0000-0002-1682-9222
Zhao, Liwei
Spisek, Radek
Kroemer, Guido
Galluzzi, Lorenzo
Article History
Received: 9 October 2020
Revised: 6 November 2020
Accepted: 9 November 2020
First Online: 26 November 2020
Conflict of interest
: J.F. and R.S. are full-time employees of Sotio. O.K. is a scientific co-founder of Samsara Therapeutics. G.K. has been holding research contracts with Bayer Healthcare, Genentech, Glaxo Smyth Kline, Institut Mérieux, Lytix Pharma, PharmaMar, Sotio, and Vasculox. He is on the Board of Directors of the Bristol Myers Squibb Foundation France and is a scientific co-founder of everImmune, Samsara Therapeutics, and Therafast Bio. L.G. received research support from Lytix and Phosplatin, consulting fees from OmniSEQ, Astra Zeneca, Inzen, and the Luke Heller TECPR2 Foundation, and is a member of the Scientific Advisory Committee of Boehringer Ingelheim, The Longevity Labs, and OmniSEQ. All other authors have no conflicts to declare.